Best in Biotech 24 Oct 2023 Seven molecular glue startups looking to stick around in the biotech industry …cancer, inflammation, metabolic diseases, and other diseases. Degron also predicts and selects potential molecular glue degrader targets by analysis of its in-house collection of chemical and target data, as well… October 24, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jan 2017 The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge …with AbbVie, but its technology is also reaching neurodegenerative diseases with its €1B collaboration with Denali (US). Founded in 2011, Mission Therapeutics focuses on diseases associated with the ubiquitin cell… January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2025 Top biotech deals of December 2024 …molecules (PHICS Technology) for metabolic diseases. It works by creating a bond between a kinase enzyme and a particular target in order to inhibit its function. Photys is set to… January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Dec 2025 Top biotech deals in November 2025 …of RNAi is to silence certain genes and tone down gene expression linked to diseases, and in the case of the SanegeneBio deal, the focus is on metabolic diseases. SanegeneBio can rake in up to $1.2 billion in… December 8, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 13 Sep 2023 PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues,… September 13, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Nov 2017 The World’s Deadliest Diseases: How is Biotech Fighting Them? …by researchers at the National Reference Center for Human Prion Diseases (NRPE) in Zurich are expected at the end of this year. Deadly diseases are still around worldwide, and this… November 14, 2017 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Aug 2025 10 biotech companies you should know about in Spain …the BO-112 and pembrolizumab combination in patients who have progressed on anti-PD-1-based therapy in refractory advanced malignant melanoma. Integra Therapeutics Technology: Gene writing tools Disease areas: Genetic diseases, oncology, and… August 19, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Aug 2024 Seven companies transforming the biotech industry in Italy …The company is leveraging these AAV vectors to target specific mutations that cause retinal diseases and correct defective genes responsible for the diseases to halt or even reverse the progression… August 22, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 …delivered to the kidney, which has historically been a challenging organ to access for genetic medicines, for the treatment of systemic diseases and renal diseases. It does this with the… June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019 Top 10 Biotechs in Lausanne …diagnostics Sophia Genetics applies AI to the analysis of the human genome with the goal of making personalized treatment recommendations to patients with cancer or genetic diseases. The company has… May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Interview 28 Nov 2022 Breaking barriers to gene therapies for childhood rare diseases The majority of known rare genetic diseases affect children, and gene therapies could help them live normal lives. Miquel Vila-Perelló, CEO and co-founder of the Spanish biotech SpliceBio, outlines how… November 28, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential …white blood cell that makes infection-fighting proteins called antibodies. CAR-T researchers are currently very focused on a group of autoimmune diseases referred to as B-cell-mediated diseases, which includes lupus. In… December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email